Diagnostic value of 18F-FDG PET/MRI for staging in patients with endometrial cancer.
Hideaki TsuyoshiTetsuya TsujikawaShizuka YamadaHidehiko OkazawaYoshio YoshidaPublished in: Cancer imaging : the official publication of the International Cancer Imaging Society (2020)
Non-contrast 18F-FDG PET/MRI, which combines the individual advantages of PET and MRI, offers a high diagnostic value equivalent to that of ceMRI for assessment of the primary tumor, and equivalent to that of ceCT for the assessment of nodal and distant metastatic staging, in patients with endometrial cancer. These findings suggest that 18F-FDG PET/MRI might provide an alternative diagnostic strategy to conventional imaging modalities in the preoperative staging of endometrial cancer.